Harnessing Complex Ecosystems for Breakthrough Innovations
Empowering Leading Companies to Ignite Innovations into Industrial Milestones
We provide high-value temporary resources to companies and academia for R&D and BD scopes
Access to specialized expertise
Enhanced KOL and stakeholder engagement
A holistic project approach
Accelerated product development and time-to-Market
Strategic positioning in competitive landscape
R&D masterplan value-driven and aligned with end-user expectations.
Trending Topics
Catalyzing Cross-Industry Innovation Through Strategic R&D Partnerships
In the fast-paced world of innovation, bridging the gap between groundbreaking research and its application across industries requires not just expertise, but a visionary approach to collaboration. For over two decades, Chelonia has led the charge in forging such transformative partnerships. Our mission is clear: to assist diverse industries in harnessing the power of scientific research, turning it into the engine of their R&D platforms and driving forward their industrial solutions.
Trusted Among Leaders
Established in 2002, Chelonia is a renowned partner for top organizations, driving industry-wide success and innovation through selective, high-impact public-private collaborations.
Mastering KOL Engagement: The Keystone of Innovation Strategy
Revolutionize your project roadmaps with our expertise in cutting-edge scientific research methodologies and strategic development planning. Our unique selling proposition lies in in our specialized approach to KOL engagement and stakeholder management, ensuring your innovations are informed by the latest industry insights and supported by key industry figures.
Featured Collaborative Innovators
Dedication. Expertise. Passion.
Highlighting a selection of distinguished contributors from our extensive network of global experts
Arieh Warshel
Nobel Prize-Winning Chemist 2013
Piero Carninci
Human Technolpole and RIKEN
Zsolt Lavotha
Strategic Advisor and former Pfizer Chairman
Torsten Schwede
University of Basel
Igor V. Tetko
Helmholtz Zentrum München
Institute of Structural Biology
Gary Pisano
Harvard Business School
James Beacham
ATLAS, CERN
Manuel C. Peitsch
DrugReKindle Initiative at Chelonia SA
Sabra Klein
Johns Hopkins Bloomberg School of Public Health